openPR Logo
Press release

LuQa and DJ Fredy Muks Unveil Sultry Summer Anthem "Lost''

07-26-2024 12:04 AM CET | Fashion, Lifestyle, Trends

Press release from: ABNewswire

LuQa and DJ Fredy Muks Unveil Sultry Summer Anthem "Lost''

Los Angeles, CA - July 25, 2024 - Italian-born sensation LuQa, known for his captivating blend of R&B and Pop reminiscent of the iconic sounds of the '90s, joins forces with acclaimed international music producer DJ Fredy Muks to unveil a scintillating summer anthem titled "Lost." This collaboration promises to ignite the airwaves with its intoxicating fusion of hard-hitting beats, electrifying guitars, and pulsating bass, showcasing LuQa's distinctive style and magnetic charisma. With a musical journey steeped in reverence for legends like Michael Jackson and Lionel Richie, Luqa's artistry exudes a timeless allure while infusing a fresh, contemporary vibe.

Image: https://www.abnewswire.com/uploads/f926a64a1ae2907b01d81f016b7a180f.jpg

His debut album, "The End," received widespread acclaim for its evocative storytelling and raw emotion, while his recent single, "A New Dawn," resonates with themes of hope and renewal, serving as a testament to his versatility and depth as an artist.

A self-made and independent force in the industry, LuQa's motorcycle-riding, MotoGP-racing persona injects an edgy intensity into his delivery, captivating audiences with infectious energy and soul-stirring vocals. As a multilingual singer-songwriter, LuQa's passion for American music led him on a journey across Europe before finding his home in Los Angeles, where he continues pushing his craft's boundaries.

Image: https://www.abnewswire.com/uploads/e6749774da21dfaee6e4f03be7d5b502.png

In collaboration with DJ Fredy Muks, a visionary in his own right and a leader in promoting African music on the global stage, LuQa's sultry summer anthem "Lost" promises to captivate listeners worldwide, solidifying his status as a rising star in the music industry. "Lost marks LuQa's first attempt at AfroPop music, with DJ Fredy Muks being the producer who welcomed him into the genre."

For more information on LuQa and his latest projects, visit:

Instagram: https://www.facebook.com/LuQamusic

LISTEN TO "LOST" & MORE:

https://ampl.ink/em2YE?fbclid=PAZXh0bgNhZW0CMTEAAaYaCamSJeFDGAYMGjkj1LhS1oprSJeAO-Kz7z4WANd_7Bg0IUXJfpY7p0_aem_svz8OEixSR6biiwS46vPAw

Facebook: https://www.facebook.com/LuQamusic

X: https://twitter.com/LuQa_

YouTube: https://youtube.com/@LuQa1

Spotify: https://open.spotify.com/artist/75Oj2K3mDhJXBCQVWfBdjL

LuQa's collaboration with DJ Fredy Muks heralds a new era of musical innovation and artistic expression, offering audiences an unforgettable sonic experience that embodies the essence of summer allure.

Media Contact
Company Name: JCE Music Group
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=luqa-and-dj-fredy-muks-unveil-sultry-summer-anthem-lost]
Phone: 818-884-6101
Country: United States
Website: https://www.facebook.com/LuQamusic



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LuQa and DJ Fredy Muks Unveil Sultry Summer Anthem "Lost'' here

News-ID: 3599196 • Views:

More Releases from ABNewswire

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Retinal Vein Occlusion Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Retinal Vein Occlusion pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore

All 5 Releases


More Releases for LuQa

Air Charter Services Market Forecast Indicates 3.4% CAGR Through 2032
Air Charter Services Market size was valued at USD 29.57 Billion in 2024 and the total Air Charter Services revenue is expected to grow at a CAGR of 3.4% from 2025 to 2032, reaching nearly USD 38.64 Billion in 2032. Air Charter Services Market Overview: The Air Charter Services Market is witnessing robust expansion, driven by the growing demand for flexible, time-efficient, and personalized travel solutions. Unlike commercial aviation, air charter services
Air Charter Services Market Set to Climb to USD 38.64 Billion by 2032 Amid Stead …
Air Charter Services Market size was valued at USD 29.57 Billion in 2024 and the total Air Charter Services revenue is expected to grow at a CAGR of 3.4% from 2025 to 2032, reaching nearly USD 38.64 Billion in 2032. Air Charter Services Market Overview: The air charter services market has gained momentum in recent years, offering flexible, private, and time-efficient travel solutions for individuals, corporations, and government entities. Unlike commercial airlines,
Trulinco: Travel the World Without Language Worries
Introduction In today's interconnected world, the allure of exploring new cultures, savouring diverse cuisines, and immersing oneself in breathtaking landscapes has never been stronger. However, the fear of language barriers often holds back many individuals from embarking on their dream adventures. Language can indeed be a daunting obstacle, hindering communication, limiting cultural experiences, and potentially leading to misunderstandings. Enter Trulinco, a revolutionary real-time language translation app that empowers travellers to break down
Hypertrophic Scar Treatment market
The global Hypertrophic Scar Treatment market report published by Reports and Data assesses the Hypertrophic Scar Treatment market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Hypertrophic Scar Treatment market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and R&D activities
Global Specialty Pharmaceutical Market to 2025| Purdue Pharma, Tevu Pharma, SEP, …
Researchmoz added Most up-to-date research on “Global Specialty Pharmaceutical Market Insights, Forecast to 2025” to its huge collection of research reports. This report studies the global market size of Specialty Pharmaceutical in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Specialty Pharmaceutical in these regions. To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1932370 This research report categorizes the
Specialty Pharmaceutical Market Insights and Growth Prospect 2017
Bigmarketresearch added Most up-to-date research on "Global Specialty Pharmaceutical Sales Market Report 2017" to its huge collection of research reports. In this report, the global Specialty Pharmaceutical market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Request sample report @ https://www.bigmarketresearch.com/request-sample/1164531 Global Specialty Pharmaceutical market competition by top manufacturers/players,